Stocks trading below an RSI of 30 are generally considered to be in the oversold zone, indicating that they may have experienced excessive selling pressure in the short term. This technical condition often suggests potential for a price rebound or trend reversal, making such stocks attractive to value and swing traders.
What is RSI and why is it important?
The Relative Strength Index (RSI) is a widely used technical tool that measures the momentum and strength of a stock’s price movements on a scale of 0 to 100. An RSI above 70 often signals that a stock is overbought and may face a correction, while below 30 suggests it is oversold and might rebound.
The Relative Strength Index (RSI) is important because it measures the momentum and strength of a stock’s price movements on a scale of 0 to 100. An RSI above 70 often signals that a stock is overbought and may face a correction, while below 30 suggests it is oversold and might rebound. Below are list of stock trading below RSI level 30:
Rallis India Limited
Rallis India Limited, a subsidiary of Tata Chemicals, is a leading agrochemical company based in Mumbai. It manufactures and markets crop protection products, fertilizers, seeds, and animal nutrition solutions. The company also provides contract manufacturing services and offers bio-fertilizers, micro-nutrients, and household pest control products globally.
With market capitalization of Rs. 5,019.24 cr, the shares of Rallis India Ltd are closed at Rs. 258.10, down by 3.82 percent from its previous close of Rs. 268.35 per share. With a current RSI of 25.87, the stock is technically in oversold territory and may attract investor attention for a possible rebound if buying momentum strengthens.
Cohance Lifesciences Limited
Cohance Lifesciences Limited, formerly known as Suven Pharmaceuticals Limited, is a Hyderabad-based company engaged in contract research, development, and manufacturing of APIs, intermediates, specialty chemicals, and formulated drugs for pharmaceutical, biotechnology, and chemical firms across India, the US, Europe, and globally. It offers small molecule APIs, antibody drug conjugates, oligonucleotide building blocks, and specialty chemicals like agrochemicals. Founded in 1989, the company became Cohance Lifesciences in May 2025 and operates as a subsidiary of Berhyanda Limited.
With market capitalization of Rs. 28,717.40 cr, the shares of Cohance Lifesciences Limited are closed at Rs. 750.65, down by 3.63 percent from its previous close of Rs. 778.95 per share. With a current RSI of 26.38, the stock is technically in oversold territory and may attract investor attention for a possible rebound if buying momentum strengthens.
Zee Entertainment Enterprises Limited
Zee Entertainment Enterprises Limited, founded in 1982 and based in Mumbai, is a leading Indian media and entertainment company. It operates numerous Hindi and regional TV channels, produces and distributes films through Zee Studios, runs the OTT platform Zee5, and manages music, digital, and international broadcasting businesses.
With market capitalization of Rs. 9,643.61 cr, the shares of Zee Entertainment Enterprises Limited are closed at Rs. 100.40, down by 1.47 percent from its previous close of Rs. 101.90 per share. The stock’s current RSI of 27.88 indicates it is oversold and may catch investor’s attention for a possible rebound if buying momentum rises.
Maharashtra Scooters Limited
Maharashtra Scooters Ltd., founded in 1975 and based in Pune, is an investment company engaged in securities and treasury operations. It is a subsidiary of Bajaj Holdings & Investment Limited and focuses on fund management and long-term investments in India.
With market capitalization of Rs. 17,383.88 cr, the shares of Maharashtra Scooters Limited are closed at Rs. 15,210.90, down by 4.34 percent from its previous close of Rs. 16,199.95 per share. With a current RSI of 23.49, the stock is considered oversold and may attract investor interest for a potential rebound if buying activity increases.
Written by Akshay Sanghavi
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
